Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Egis prepares new AMPA receptor antagonists

Dec. 8, 1997

Analgesics under evaluation at Ortho

Dec. 8, 1997

Structurally distinct class of 5-HT1B antagonists prepared at SmithKline Beecham

Dec. 8, 1997

Egis reports safe and effective new anxiolytic

Dec. 8, 1997

Cyberonics receives EU approval for expanded use of VNS

Dec. 5, 1997

Chiroscience files MAA for Chirocaine

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

New antipsychotic reported in development at Merck KGaA

Dec. 4, 1997

Profile of an mGluR2/mGluR3 agonist

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...